Invitae Executive Appointed to National Health Information Technology Advisory Committee
– Deven McGraw to serve a 3-12 months expression commencing in 2023 –
SAN FRANCISCO, Dec. 19, 2022 /PRNewswire/ — Invitae (NYSE: NVTA), a primary health care genetics corporation, declared the appointment by the U.S. Governing administration Accountability Business (GAO) of Deven McGraw, guide of details stewardship and knowledge sharing at Invitae, to the Countrywide Health Information and facts Technological know-how Advisory Committee (HITAC).
Established as element of the 21st Century Cures Act in 2016, HITAC offers recommendations to the National Coordinator for Overall health Information and facts Know-how on guidelines, benchmarks, implementation specifications, and certification requirements relating to the implementation of a wellbeing facts technological innovation infrastructure that improvements the electronic accessibility, trade, and use of overall health data.
“I am honored to be appointed to HITAC to aid shape the nation’s wellbeing info policy, significantly as it relates to growing accessibility to crucial patient wellbeing knowledge in a way that is moral and transparent,” mentioned McGraw. “By my participation on HITAC’s 2022 Adopted Benchmarks Activity Drive subcommittee, I have presently experienced the opportunity to suggest on the present established of ONC adopted standards and am searching forward to continuing my get the job done with this outstanding group on the full committee. Invitae’s mission to boost accessibility to and interoperability of consented patient overall health information will supply a worthwhile viewpoint as we get the job done to the mission of improving upon health care IT.”
McGraw’s expression will start off on January 1, 2023. McGraw also serves on a subcommittee advising the State of California on its details sharing framework policies and techniques. In her function at Invitae, McGraw is guide for knowledge stewardship and details sharing. She co-established and was the Chief Regulatory Officer of Ciitizen, a health and fitness technologies organization acquired by Invitae that functions to permit people to collect, handle, and share their health-related details. Her previous encounter incorporates serving as the Deputy Director of Overall health Information and facts Privateness in just the U.S. Section of Wellbeing and Human Services Office environment of Civil Legal rights, as the Acting Main Privacy Officer for the Place of work of the Nationwide Coordinator for Well being IT, and as a partner with Manatt, Phelps & Phillips, LLP. McGraw obtained her Juris Doctor from Georgetown University Law Heart and her Master of General public Overall health from Johns Hopkins Bloomberg University of Community Wellness.
For additional facts on the committee, pay a visit to the HITAC web page.
Invitae is a main healthcare genetics organization dependable by tens of millions of clients and their suppliers to produce well timed genetic facts simplified by digital technology. With accurate and actionable solutions to reinforce medical final decision-making, Invitae offers persons and their people highly effective, customized insights that could enhance and lengthen their life. Invitae’s genetics industry experts apply a rigorous approach to knowledge and investigation, serving as the basis of their mission: to provide detailed genetic details into mainstream medicine to enhance health care for billions of individuals.
To understand far more, check out invitae.com and abide by for updates on Twitter, Instagram, Facebook and LinkedIn @Invitae.
Protected Harbor Statement
This press launch includes ahead-looking statements in just the this means of the Personal Securities Litigation Reform Act of 1995, including statements relating to the company’s mission to enhance entry to and interoperability of consented individual well being information. Forward-looking statements are matter to risks and uncertainties that could bring about true effects to differ materially, and described results need to not be regarded as as an indicator of foreseeable future performance. These threats and uncertainties involve, but are not constrained to: the company’s background of losses the firm’s potential to contend the company’s failure to regulate expansion successfully the company’s want to scale its infrastructure in progress of demand from customers for its checks and to raise demand for its exams the company’s means to use quickly switching genetic data to interpret exam outcomes accurately and regularly protection breaches, reduction of knowledge and other disruptions rules and polices applicable to the firm’s small business and the other challenges established forth in the firm’s filings with the Securities and Exchange Commission, including the dangers set forth in the firm’s Quarterly Report on Form 10-Q for the quarter finished September 30, 2022. These forward-wanting statements discuss only as of the date hereof, and Invitae Corporation disclaims any obligation to update these forward-looking statements.
Resource Invitae Company